Search Results

You searched for : LatestBristolMyersSquibbNews

	Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma ... Jul 17
	Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-... Jun 25
	European Medicines Agency Validates Bristol Myers Squibbâ€™s Application for Opdivo ... Jan 05
	European Medicines Agency Validates Bristol Myers Squibbâ€™s Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis If approved, Zeposia would be the first oral sphingosine-1-phosphate (S1P) receptor modulator for the treatment of ulcerative colitis.... Dec 28
	Bristol Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed Methylated Glioblastoma Multiforme ... Dec 23
	Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic for Adult Patients with Myelofibrosis If approved, Inrebic will become the first new therapy for myelofibrosis in Europe in nearly a decade.... Dec 11
	Bristol Myers Squibb Presents Analyses from Pivotal QUAZAR AML-001 Study of Onureg Results demonstrated treatment with Onureg improved overall survival, compared to placebo, in patients with AML in first remission.... Dec 08
	Bristol Myers Squibb Receives European Commission Approval for Opdivo Bristol Myers Squibb announced the approval of Opdivo for the treatment of adults with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma ... Nov 25
	Decreases in Americans' Primary Care Visits May Lead to Late Diagnoses of Potentially Serious Conditions The Bristol Myers Squibbâ€“Pfizer Alliance, with the support of leading advocacy organizations and medical societies, announces the launch of the No Time to Wait ... Oct 26
	USFDA Accepts for Priority Review Applications for OPDIVO in Combination with CABOMETYX in Advanced Renal Cell Carcinoma Results from CheckMate -9ER recently presented during a Presidential Symposium at the European Society for Medical Oncology Virtual Congress... Oct 19
10 Matching result(s) found!

-Advertisements-

Trending Now
	Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
	Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
	Akshay Tritiya Parna Mahotsav heldMay 16, 2024
	IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
	Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
	India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
	The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
	Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
	AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
	Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024
	On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology NursesMay 14, 2024
	Shiprocket announces Shiprocket Growth Academy to upskill 100,000 Indian MSMEs through eCommerce learningMay 14, 2024
	5 baby essential gifts for new and expecting momsMay 13, 2024
	BLUM India launches its first State-of-the-Art Experience Centre in HyderabadMay 13, 2024
	Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in IndiaMay 13, 2024
	Setback for Organ Transplantion: First Human to Receive Pig Kidney DiesMay 13, 2024
	Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
	Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
	The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
	Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024

Search Results

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy

European Medicines Agency Validates Bristol Myers Squibbâ€™s Application for Opdivo

European Medicines Agency Validates Bristol Myers Squibbâ€™s Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis

Bristol Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed Methylated Glioblastoma Multiforme

Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic for Adult Patients with Myelofibrosis

Bristol Myers Squibb Presents Analyses from Pivotal QUAZAR AML-001 Study of Onureg

Bristol Myers Squibb Receives European Commission Approval for Opdivo

Decreases in Americans' Primary Care Visits May Lead to Late Diagnoses of Potentially Serious Conditions

USFDA Accepts for Priority Review Applications for OPDIVO in Combination with CABOMETYX in Advanced Renal Cell Carcinoma

Trending Now